PIMTREA Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Pimtrea, and when can generic versions of Pimtrea launch?
Pimtrea is a drug marketed by Novast Labs and is included in one NDA.
The generic ingredient in PIMTREA is desogestrel; ethinyl estradiol. There are eight drug master file entries for this compound. Seventeen suppliers are listed for this compound. Additional details are available on the desogestrel; ethinyl estradiol profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Pimtrea
A generic version of PIMTREA was approved as desogestrel; ethinyl estradiol by DURAMED PHARMS BARR on August 12th, 1999.
Summary for PIMTREA
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 4 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for PIMTREA |
Drug Sales Revenues: | Drug sales revenues for PIMTREA |
DailyMed Link: | PIMTREA at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for PIMTREA
US Patents and Regulatory Information for PIMTREA
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Novast Labs | PIMTREA | desogestrel; ethinyl estradiol | TABLET;ORAL-28 | 091247-001 | Aug 1, 2013 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |